Loading this company
Zoetis Inc.
ZTSPrices in USD
TickerWorth ScoreB58/100
What we think
Priced below our range of $83.42 to $145.04.A range by design: peer multiples and our researched mid-cycle DCF.
Price
$80.04USD up +$0.45 (+0.57%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 2 models, on today’s numbers
$83.42–$145.04
A range by design: peer multiples and our researched mid-cycle DCF.
What the price needs: revenue growth of -2.8%/yr for 5 years (our model assumes 2.0%).
Led by peer multiples (P/E, EV/EBITDA, P/S) · Cyclical business
Price $80.04Priced · Prices are delayed.
Is it a good business?
- Valuation50 out of 100
- Growth50 out of 100
- Financial health33 out of 100
- Dividend100 out of 100
- Past performance67 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro.
Try Pro free for 7 days — no card, auto-downgrade to Free.
The street
Analysts’ mean target
$94.43 across 14 analysts
The high and low of the analyst range is part of Pro.
Try Pro free for 7 days — no card, auto-downgrade to Free.
What does it do?
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in United States. The company employs roughly 14,500 people.
Revenue: United States Segment 55% · International Segment 45%
Key stats
52-week range$68.77–$148.30
- Open
- $79.64
- Day high
- $80.24
- Day low
- $79.03
- Previous close
- $79.59
- Volume
- 3,645,662 · 0.70× avg
- Average volume
- 5,231,804
- Market cap
- $33,074,417,664.00
- P/E (TTM)
- 13.16
- Earnings per share
- $6.08
- Beta
- 0.74
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Changed leadership or its board
- Issued a public disclosure (Reg FD)
- Changed leadership or its board
- Reported quarterly or annual results
- Changed leadership or its board
- Issued a public disclosure (Reg FD)
- Reported quarterly or annual results
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro.
Try Pro free for 7 days — no card, auto-downgrade to Free.
Not investment advice. TickerWorth Score is a model output.